PROCEPT BioRobotics (PRCT) Asset Writedowns and Impairment (2020 - 2026)
PROCEPT BioRobotics (PRCT) reported Asset Writedowns and Impairment of $274000.0 for Q1 2026, down 16.97% year-over-year from $330000.0 in Q1 2025, and up 178.96% on a QoQ basis from -$347000.0 in Q4 2025.
PROCEPT BioRobotics (PRCT) has 7 years of Asset Writedowns and Impairment data on file, last reported at $274000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment fell 16.97% year-over-year to $274000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $163000.0 (down 86.07% YoY) and the FY2025 annual result came in at $219000.0, down 73.93% from the prior year.
- Asset Writedowns and Impairment rose to $274000.0 in Q1 2026 per PRCT's latest filing, from -$347000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $581000.0 in Q3 2023 and bottomed at -$347000.0 in Q4 2025.
- The 5-year median for Asset Writedowns and Impairment is $207000.0 (2023), against an average of $199166.7.
- The widest annual swing landed in 2023, when Asset Writedowns and Impairment soared 567.82%; it then slumped 190.36% in 2025.
- Tracing PRCT's Asset Writedowns and Impairment over 5 years: stood at -$25000.0 in 2022, then jumped by 2424.0% to $581000.0 in 2023, then slumped by 33.91% to $384000.0 in 2024, then slumped by 190.36% to -$347000.0 in 2025, then jumped by 178.96% to $274000.0 in 2026.
- Per Business Quant, the three latest PRCT Asset Writedowns and Impairment figures stand at $274000.0 (Q1 2026), -$347000.0 (Q4 2025), and $76000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PROCEPT BioRobotics | 1.58 Bn | 1.33 Bn | 53.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 274,000.00 |
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | -347,000.00 |
| Dec 31, 2025 | -347,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 330,000.00 |
| Mar 31, 2025 | 330,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Sep 30, 2024 | 456,000.00 |
| Sep 30, 2024 | 456,000.00 |
| Sep 30, 2023 | 581,000.00 |
| Sep 30, 2023 | 581,000.00 |
| Jun 30, 2023 | 186,000.00 |
| Jun 30, 2023 | 186,000.00 |
| Mar 31, 2023 | 228,000.00 |
| Mar 31, 2023 | 228,000.00 |
| Dec 31, 2022 | -25,000.00 |
| Dec 31, 2022 | -25,000.00 |
| Sep 30, 2022 | 87,000.00 |
| Sep 30, 2022 | 87,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Dec 31, 2020 | 87,000.00 |
| Dec 31, 2020 | 87,000.00 |